The use of the implantable left ventricular assist device (LVAD) for patients before a heart transplant is evolving and becoming more common. Almost all U.S. cardiac transplant programs have an implantable LVAD, either the HeartMate (Thoratec, Oakland, California) or Novacor (World Heart, Ottawa, Canada). With better technology, more predictable clinical results and greater widespread acceptanc...